Core Lab Reports Record Net Income and EPS for Q4 2008; Annual Free Cash Flow at All-Time High; Company Repurchases Discounted Debt
The Company also reached a record high of 28.3% for operating margins, excluding the effects of currency translation exchange losses. Core continued to benefit from its de-emphasis of Russian operations and its downsizing of Mexican, Venezuelan, and Nigerian operations over the past three years, as the Company focused on development and production-related projects almost to the exclusion of volatile exploration-related activities. Reservoir Description operations continued to benefit from internationally based crude-oil development projects, and Production Enhancement operations focused on further exploitation of the North American gas-shale plays. Reservoir Management posted its most profitable quarter in Company history, as clients increased participation in projects related to unconventional crude-oil and natural gas developments.
For all of 2008, Core reported records for revenue, net income, EPS, cash from operations, and free cash flow. Annual revenue for 2008 was
Segment Highlights
Core Laboratories reports results under three operating segments: Reservoir Description, Production Enhancement, and Reservoir Management.
Reservoir Description
Reservoir Description operations reported quarterly revenues of
Demand for Core’s Reservoir Description services, many of which are proprietary and patented, remained robust. This is especially the case for services used to characterize reservoir fluids, which include natural gases, crude oil and its derived products, and formation waters. Results from Core’s PVT phase-behavior studies play a key role in the design and optimization of production and production-enhancement strategies, as well as in the design of surface production facilities needed for efficient reservoir management. Crude-oil distillations and assays are used to determine the most cost-effective fractionation and best yield of derived petroleum products, such as distillates, gasoline, and diesel fuels. Crude oil can be sampled directly from the producing reservoir, at the wellhead, from a transport vessel or pipeline, or at any point as it is moved to the refinery. Proper testing and inspection of crude oils and their derived products ensures that oil companies can maximize cash flow from their purchases and sales. These services provide additional value-add at lower commodity price decks when every basis point becomes more significant to the oil companies.
Production Enhancement
Production Enhancement operations posted
Core’s proprietary and patented fracture diagnostic technology and services continue to increase market penetration in gas-shale developments. Core’s newest perforating technology, the SuperHERO Plus+(TM) charge, is a high-performance, ultra-low debris charge. Improvements to the Company’s patented HWM(SM) powdered metal liner compositions and proprietary and patented high-explosive formula and design have improved formation penetration by as much as 15%. Increased formation penetration with minimal formation damage yields higher initial production rates and greater ultimate recovery of hydrocarbons from the formation. The new charge also has the potential to significantly lower the producing formation’s breakdown pressure, reducing the cost of hydraulic fracture stimulation programs. The new technology is proving to be very effective in gas-shale developments.
Reservoir Management
Reservoir Management operations reported its most profitable quarter in Company history, with record quarterly revenue and operating profit of
The record results were due to increased demand for the Company’s joint-industry studies — including those associated with North American gas-shales — for the Company’s products and services in the deepwater basins offshore
In addition, a record number of monitoring systems for reservoir temperature and pressure were delivered to clients in
Free Cash Flow, Debt Repurchase, Share Repurchase Program, and 2009 Capex Program
For the fourth quarter of 2008, Core generated approximately
Core continued to use its free cash to enhance shareholder value by repurchasing significantly discounted debt in the quarter. The Company repurchased debt with a notional value of
On
The Company is reducing its capital expenditure plans for 2009; they are projected at
Implementation of FSP-APB 14-1
The Company will implement FASB Staff Position No. APB 14-1 (APB 14-1) beginning in the first quarter of 2009 as mandated by the FASB. APB 14-1 determines accounting treatment for convertible debt instruments that may be settled partially, or fully, in cash. Core currently has approximately
Core believes that rate will be 7.48% as a total effective interest rate, which will produce a non-cash interest expense of approximately
Q1 2009 Earnings Guidance
For the first quarter of 2009, Core expects revenue to range between
The Company has scheduled a conference call to discuss this quarter’s earnings announcement. The call will begin at
Core Laboratories N.V. (www.corelab.com) is a leading provider of proprietary and patented reservoir description, production enhancement, and reservoir management services used to optimize petroleum reservoir performance. The Company has over 70 offices in more than 50 countries and is located in every major oil-producing province in the world.
This release includes forward-looking statements regarding the future revenues, profitability, business strategies and developments of the Company made in reliance upon the safe harbor provisions of Federal securities law. The Company’s outlook is subject to various important cautionary factors, including risks and uncertainties related to the oil and natural gas industry, business conditions, international markets, international political climates and other factors as more fully described in the Company’s 2007 Form 10-K filed on
CORE LABORATORIES N.V. & SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(amounts in thousands, except share and per share data)
(UNAUDITED)
Three Months Ended Twelve Months Ended
31 31 31 31
December December December December
2008 2007 2008 2007
REVENUES $201,188 $176,359 $780,836 $670,540
EXPENSES:
Costs of services
and sales 130,194 116,046 514,782 449,191
General and
administrative expenses 9,341 9,039 31,646 33,837
Depreciation and
amortization 5,696 4,966 21,773 19,476
Other income, net (4,722) (12,962) (2,401) (15,812)
INCOME BEFORE INTEREST EXPENSE
AND INCOME TAX EXPENSE 60,679 59,270 215,036 183,848
Interest expense 408 670 6,431 2,551
INCOME BEFORE INCOME TAX EXPENSE 60,271 58,600 208,605 181,297
Income tax expense 19,227 23,074 65,002 60,192
NET INCOME $41,044 $35,526 $143,603 $121,105
Diluted Earnings Per Share:
Net Income $1.76 $1.45 $6.00 $4.96
WEIGHTED AVERAGE DILUTED COMMON
SHARES OUTSTANDING 23,289 24,530 23,944 24,408
SEGMENT INFORMATION:
Revenues:
Reservoir Description $108,730 $100,018 $435,425 $374,455
Production Enhancement 75,439 63,264 293,017 244,830
Reservoir Management 17,019 13,077 52,394 51,255
Total $201,188 $176,359 $780,836 $670,540
Income Before Interest and Taxes:
Reservoir Description $23,376 $35,557 $100,817 $99,864
Production Enhancement 21,261 19,222 93,005 68,900
Reservoir Management 5,946 4,479 16,224 14,650
Subtotal 50,583 59,258 210,046 183,414
Corporate and other 10,096 12 4,990 434
Total $60,679 $59,270 $215,036 $183,848
CORE LABORATORIES N.V. & SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(amounts in thousands)
ASSETS: 31 December 2008 31 December 2007
(Unaudited)
Cash and Cash Equivalents $36,138 $25,617
Accounts Receivable, net 144,293 137,231
Inventories, net 34,838 29,363
Other Current Assets 26,759 28,488
Total Current Assets 242,028 220,699
Property, Plant and Equipment, net 103,463 93,038
Intangibles, Goodwill and Other
Long Term Assets, net 192,160 191,053
Total Assets $537,651 $504,790
LIABILITIES AND SHAREHOLDERS' EQUITY:
Accounts Payable $41,588 $39,861
Other Current Liabilities 54,102 58,179
Total Current Liabilities 95,690 98,040
Long-Term Debt and Lease Obligations 238,658 300,000
Other Long-Term Liabilities 45,150 44,607
Shareholders' Equity 158,153 62,143
Total Liabilities and Shareholders'
Equity $537,651 $504,790
CORE LABORATORIES N.V. & SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENT OF CASH FLOW
(amounts in thousands)
(Unaudited)
Twelve Months Ended
31 December 2008
CASH FLOWS FROM OPERATING ACTIVITIES $155,207
CASH FLOWS USED FOR INVESTING ACTIVITIES (41,108)
CASH FLOWS USED FOR FINANCING ACTIVITIES (103,578)
NET CHANGE IN CASH AND CASH EQUIVALENTS 10,521
CASH AND CASH EQUIVALENTS, beginning of
period 25,617
CASH AND CASH EQUIVALENTS, end of period $36,138
Non-GAAP Information
Management believes that the exclusion of certain expenses and credits
enables it to evaluate more effectively the Company's operations
period-over-period and to identify operating trends that could otherwise
be masked by the excluded items. For this reason, we used certain
non-GAAP measures that exclude these non-recurring items; we felt that
presentation provides the public a clearer comparison with the numbers
reported in prior periods.
Reconciliation of Income Before Interest Expense and Income Tax Expense
Three Three Twelve Twelve
Months Months Months Months
Ended Ended Ended Ended
31 31 31 31
December December December December
2008 2007 2008 2007
Income before interest
expense and income tax
expense $60,679 $59,270 $215,036 $183,848
Gain on sale of building - (10,220) (1,054) (10,220)
Foreign exchange loss 4,670 - 6,555 -
Gain on repurchase of
convertible notes (8,323) - (8,323) -
Severance - - 758 -
Non-income related taxes - - 5,030 -
Income before interest
expense and income tax
expense excluding specific
items $57,026 $49,050 $218,002 $173,628
Reconciliation of Income Before Interest Expense and Income Tax Expense
Three Months
Ended
Three Months Ended 31 31 December
December 2008 2007
Reservoir Production Reservoir Reservoir
Description Enhancement Management Description
Income before interest
expense and income tax
expense $23,376 $21,261 $5,946 $35,557
Gain on sale of building - - - (10,220)
Foreign exchange loss 2,975 2,129 408 -
Income before interest
expense and income tax
expense excluding
specific items $26,351 $23,390 $6,354 $25,337
Reconciliation of Net Income
Three Three Twelve Twelve
Months Months Months Months
Ended Ended Ended Ended
31 31 31 31
December December December December
2008 2007 2008 2007
Net Income $41,044 $35,526 $143,603 $121,105
Gain on sale of
building (net of tax) - (7,767) (709) (7,767)
Foreign exchange loss
(net of tax) 3,180 - 4,510 -
Gain on repurchase of
senior exchangeable
notes (net of tax) (5,668) - (5,668) -
Severance (net of tax) - - 510 -
Debt acquisition costs
related to senior
exchangeable notes
(net of tax) - - 3,450 -
Net impact of non-income
related taxes - - 3,771 -
Change in tax rate due
to pending settlements
and other adjustments - 5,623 (2,602) 5,623
Net Income excluding
specific items $38,556 $33,382 $146,865 $118,961
Reconciliation of Diluted Earnings Per Share
Three Three Twelve Twelve
Months Months Months Months
Ended Ended Ended Ended
31 31 31 31
December December December December
2008 2007 2008 2007
Diluted Earnings per Share $1.76 $1.45 $6.00 $4.96
Gain on sale of building
(net of tax) - (0.32) (0.03) (0.32)
Foreign exchange loss
(net of tax) 0.14 - 0.19 -
Gain on repurchase of
senior exchangeable notes
(net of tax) (0.24) - (0.24) -
Severance (net of tax) - - 0.02 -
Debt acquisition costs related
to senior exchangeable
notes (net of tax) - - 0.14 -
Net impact of non-income
related taxes - - 0.16 -
Change in tax rate due to
pending settlements and
other adjustments - 0.23 (0.11) 0.23
Diluted Earnings per Share
excluding specific items $1.66 $1.36 $6.13 $4.87
Free Cash Flow
Core uses the non-GAAP measure of free cash flow to evaluate its cash
flows and results of operations. Free cash flow is an important
measurement because it represents the cash from operations, in excess of
capital expenditures, available to operate the business and fund
non-discretionary obligations. Free cash flow is not a measure of
operating performance under GAAP, and should not be considered in
isolation nor construed as an alternative to operating income, net income,
earnings per share, or cash flows from operating, investing, or financing
activities, each as determined in accordance with GAAP. You should also
not consider free cash flow as a measure of liquidity. Moreover, since
free cash flow is not a measure determined in accordance with GAAP and
thus is susceptible to varying interpretations and calculations, free cash
flow as presented may not be comparable to similarly titled measures
presented by other companies.
Computation of Free Cash Flow
(amounts in thousands)
(Unaudited)
Three Months Twelve Months
Ended Ended
31 December 31 December
2008 2008
Net cash provided by operating
activities $45,070 $155,207
Less: capital expenditures (9,347) (30,950)
Free cash flow $35,723 $124,257
SOURCE Core Laboratories